Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00674193 · ClinicalTrials.gov registry record
Evaluating Dactinomycin and Vincristine in Young Patients With Cancer
A clinical trial, sponsored by Children's Oncology Group.
- Completed
- Registry status
- 158
- Enrollment target
NCT00674193 is a clinical trial that has completed, run by Children's Oncology Group. The registered enrollment target is 158 participants.
The verdict
NCT00674193 has completed, sponsored by Children's Oncology Group.
- COMPLETED
- Registry status
- 158 participants
- Enrollment target
Study Summary
This laboratory study is evaluating how well dactinomycin and vincristine work in treating young patients with cancer. Studying samples of blood and urine in the laboratory from patients with cancer may help doctors learn how dactinomycin and vincristine affect the body and how patients will respond to treatment.
Interventions
- OTHER laboratory biomarker analysis
- OTHER pharmacological study
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 158 participants |
| Start Date | 2008-02 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00674193
The ClinicalTrials.gov registry entry for NCT00674193 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 158 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Children's Oncology Group, which has 342 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which laboratory biomarker analysis is the first listed.
NCT00674193 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00674193 about?
NCT00674193 is a clinical study titled "Evaluating Dactinomycin and Vincristine in Young Patients With Cancer". This laboratory study is evaluating how well dactinomycin and vincristine work in treating young patients with cancer. Studying samples of blood and urine in the laboratory from patients with cancer may help doctors learn how dactinomycin and vincristine affect the body and how patients will respond...
What is the current status of trial NCT00674193?
This trial is currently completed. The enrollment target is 158 participants. The study started on 2008-02.
What interventions are being tested in trial NCT00674193?
The interventions under investigation include: laboratory biomarker analysis (OTHER), pharmacological study (OTHER).
Who is sponsoring clinical trial NCT00674193?
This trial is sponsored by Children's Oncology Group, which has 342 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.